SHL Telemedicine Ltd. (NASDAQ:SHLT - Get Free Report)'s stock price traded up 23.7% during trading on Tuesday . The company traded as high as $3.87 and last traded at $3.50. 108,985 shares changed hands during trading, an increase of 1,123% from the average session volume of 8,910 shares. The stock had previously closed at $2.83.
SHL Telemedicine Stock Performance
The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.98 and a current ratio of 2.17. The business's 50-day moving average is $2.83 and its 200 day moving average is $3.75.
Hedge Funds Weigh In On SHL Telemedicine
A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd purchased a new position in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,219,610 shares of the company's stock, valued at approximately $11,351,000. SHL Telemedicine accounts for about 1.2% of Y.D. More Investments Ltd's portfolio, making the stock its 22nd largest position. Y.D. More Investments Ltd owned approximately 15.12% of SHL Telemedicine as of its most recent filing with the SEC. 20.11% of the stock is owned by institutional investors.
About SHL Telemedicine
(
Get Free Report)
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.
Further Reading
Before you consider SHL Telemedicine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SHL Telemedicine wasn't on the list.
While SHL Telemedicine currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
